CASH AND CASH EQUIVALENTS, INVESTMENTS, AND FAIR VALUE MEASUREMENTS | CASH AND CASH EQUIVALENTS, INVESTMENTS, AND FAIR VALUE MEASUREMENTS The following tables summarize information about our cash, cash equivalents, and investments by investment category as of October 31, 2024 and January 31, 2024 (in thousands): As of October 31, 2024 Fair Value Level Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Assets Cash and cash equivalents: Cash $ 86,320 $ — $ — $ 86,320 Money market funds Level 1 149,422 — — 149,422 Total cash and cash equivalents $ 235,742 $ — $ — $ 235,742 Short-term investments: U.S. Treasury securities Level 1 $ 102,526 $ 146 $ (1) $ 102,671 Corporate notes and bonds Level 2 207,437 441 (46) 207,832 U.S. agency securities Level 2 113,831 196 (13) 114,014 Total short-term investments $ 423,794 $ 783 $ (60) $ 424,517 Long-term investments: U.S. Treasury securities Level 1 $ 208,798 $ 1,107 $ (291) $ 209,614 Corporate notes and bonds Level 2 216,716 1,045 (373) 217,388 U.S. agency securities Level 2 13,457 4 (82) 13,379 Total long-term investments $ 438,971 $ 2,156 $ (746) $ 440,381 Total assets measured at fair value $ 1,098,507 $ 2,939 $ (806) $ 1,100,640 As of January 31, 2024 Fair Value Level Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Assets Cash and cash equivalents: Cash $ 43,925 $ — $ — $ 43,925 Money market funds Level 1 204,481 — — 204,481 Certificates of deposit Level 2 8,245 — — 8,245 Total cash and cash equivalents $ 256,651 $ — $ — $ 256,651 Short-term investments: U.S. Treasury securities Level 1 $ 234,776 $ — $ (1,053) $ 233,723 Corporate notes and bonds Level 2 279,248 12 (1,068) 278,192 U.S. agency securities Level 2 157,873 18 (501) 157,390 Total short-term investments $ 671,897 $ 30 $ (2,622) $ 669,305 Long-term investments: U.S. Treasury securities Level 1 $ 27,175 $ 121 $ — $ 27,296 Corporate notes and bonds Level 2 69,970 279 (67) 70,182 U.S. agency securities Level 2 90,924 303 (48) 91,179 Total long-term investments $ 188,069 $ 703 $ (115) $ 188,657 Total assets measured at fair value $ 1,116,617 $ 733 $ (2,737) $ 1,114,613 We invest in highly rated securities with a weighted average maturity of 18 months or less. As of October 31, 2024, all of our investments will mature within two years. There were no transfers between the levels of the fair value hierarchy during the three and nine months ended October 31, 2024 and 2023. As of October 31, 2024, we determined that the declines in the market value of our investment portfolio were not driven by credit-related factors. During the three and nine months ended October 31, 2024 and 2023, we did not recognize any losses on our investments due to credit-related factors. As of October 31, 2024, we had $0.1 million in continuous unrealized loss positions for more than twelve months on securities with a total fair value of $75.6 million. The tables above do not include the Company’s strategic investments in non-marketable debt and equity securities, recorded at cost, less any impairment, plus or minus observable price changes in orderly transactions for identical or similar investments of the same issuer and were $23.2 million and $16.1 million as of October 31, 2024 and January 31, 2024, respectively. Receivables related to strategic investments are classified as prepaid expenses and other current assets and other assets on the condensed consolidated balance sheet. As of October 31, 2024 and January 31, 2024, the balance of such receivables were $1.4 million and $1.1 million, respectively. During the three and nine months ended October 31, 2024, the Company incurred no impairment charges on its non-marketable strategic investments. During the three and nine months ended October 31, 2023, the Company recognized impairment charges on its non-marketable strategic investments of $0.8 million. During the three months ended October 31, 2024, the Company recognized no realized gains on its non-marketable strategic investments. During the nine months ended October 31, 2024, the Company recognized realized gains on its non-marketable strategic investments of $0.3 million. During the three and nine months ended October 31, 2023, the Company recognized realized gains on its non-marketable strategic investments of $1.5 million and $3.5 million, respectively. Impairment charges and realized gains on strategic investments are recognized in other income (expense), net. |